What question did this study set out to answer?

This study aims to highlight the delayed identification and management of cerebral toxoplasmosis in a patient undergoing immunosuppressive treatment.

A54-23 Delayed Identification of Cerebral Toxoplasmosis in a System Lupus Erythematous Patient on Mycophenolate Mofetil Monotherapy

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial reveals delayed identification of cerebral toxoplasmosis in systemic lupus erythematosus, suggesting a need for timely intervention.

This study aims to highlight the delayed identification and management of cerebral toxoplasmosis in a patient undergoing immunosuppressive treatment.
Case presentation of a 72-year-old female with systemic lupus erythematosus on mycophenolate mofetil.
Diagnosis involved brain MRI, lumbar puncture, and toxoplasma PCR.
Empiric treatment initiated for suspected infection prior to confirmatory tests.
Patient showed positive toxoplasma PCR after 25 days of hospitalization.
Despite delayed treatment, there was mild improvement in mental status post-intervention.
Discussion emphasizes the rarity of cerebral toxoplasmosis in patients on mycophenolate mofetil.

Sayegh et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial reveals delayed identification of cerebral toxoplasmosis in systemic lupus erythematosus, suggesting a need for timely intervention.